» Articles » PMID: 12454194

Loss of a 29-kilodalton Outer Membrane Protein in Acinetobacter Baumannii is Associated with Imipenem Resistance

Overview
Specialty Microbiology
Date 2002 Nov 28
PMID 12454194
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the possible causes of imipenem (IPM) resistance in multidrug-resistant isolates of Acinetobacter baumannii. Comparison of the outer membrane protein (OMP) profiles of two genomically related strains (Ab288 [IPM sensitive] and Ab242 [IPM resistant]) indicated the conspicuous loss of a 29-kDa polypeptide in the Ab242 strain. No carbapenemase activity was detected in any of these strains. The treatment of Ab288 with sodium salicylate resulted in IPM resistance and the loss of the 29-kDa OMP. In addition, IPM-resistant clones of Ab288 which were selected by repetitive culturing in increasing concentrations of this antibiotic also showed the absence of this 29-kDa OMP.

Citing Articles

Global analysis of the RNA-RNA interactome in Acinetobacter baumannii AB5075 uncovers a small regulatory RNA repressing the virulence-related outer membrane protein CarO.

Hamrock F, Ryan D, Shaibah A, Ershova A, Mogre A, Sulimani M Nucleic Acids Res. 2024; 52(18):11283-11300.

PMID: 39149883 PMC: 11472050. DOI: 10.1093/nar/gkae668.


Acinetobacter baumannii OmpA-like porins: functional characterization of bacterial physiology, antibiotic-resistance, and virulence.

Scribano D, Cheri E, Pompilio A, Di Bonaventura G, Belli M, Cristina M Commun Biol. 2024; 7(1):948.

PMID: 39107399 PMC: 11303520. DOI: 10.1038/s42003-024-06645-0.


Outer Membrane Vesicles from : Biogenesis, Functions, and Vaccine Application.

Weng Z, Yang N, Shi S, Xu Z, Chen Z, Liang C Vaccines (Basel). 2024; 12(1).

PMID: 38250862 PMC: 10818702. DOI: 10.3390/vaccines12010049.


Carbapenem resistance in from agricultural, environmental and clinical origins: South Africa in a global context.

Ramkisson T, Rip D AIMS Microbiol. 2024; 9(4):668-691.

PMID: 38173973 PMC: 10758576. DOI: 10.3934/microbiol.2023034.


Global genomic epidemiology of chromosomally mediated non-enzymatic carbapenem resistance in : on the way to predict and modify resistance.

Nageeb W, Alharbi N, Alrehaili A, Zakai S, Elfadadny A, Hetta H Front Microbiol. 2023; 14:1271733.

PMID: 37869654 PMC: 10587612. DOI: 10.3389/fmicb.2023.1271733.


References
1.
Takahashi A, Yomoda S, Kobayashi I, Okubo T, Tsunoda M, Iyobe S . Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol. 2000; 38(2):526-9. PMC: 86139. DOI: 10.1128/JCM.38.2.526-529.2000. View

2.
Silva G, Leitao G, Peixe L . Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J Clin Microbiol. 1999; 37(6):2109-10. PMC: 85053. DOI: 10.1128/JCM.37.6.2109-2110.1999. View

3.
Riccio M, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R . Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000; 44(5):1229-35. PMC: 89849. DOI: 10.1128/AAC.44.5.1229-1235.2000. View

4.
Bou G, Cervero G, Dominguez M, Quereda C . Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol. 2000; 38(9):3299-305. PMC: 87377. DOI: 10.1128/JCM.38.9.3299-3305.2000. View

5.
Limansky A, Viale A . Can composition and structural features of oligonucleotides contribute to their wide-scale applicability as random PCR primers in mapping bacterial genome diversity?. J Microbiol Methods. 2002; 50(3):291-7. DOI: 10.1016/s0167-7012(02)00040-4. View